PNI and Decision Making in Women Diagnosed with DCIS

诊断为 DCIS 的女性的 PNI 和决策

• 批准号: 6942335
• 负责人: Linda Janusek
• 金额: $ 32.56万
• 依托单位: LOYOLA UNIVERSITY OF CHICAGO
• 依托单位国家: 美国
• 财政年份: 2004
• 资助国家: 美国
• 起止时间: 2004-09-01 至 2008-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6942335
• 关键词: anxiety; behavioral /social science research tag; blood chemistry; breast neoplasms; clinical research; conflict; decision making; female; human subject; immune response; model design /development; mood disorders; neoplasm /cancer diagnosis; neoplasm /cancer therapy; patient oriented research; psychological aspect of cancer; psychological models; psychological stressor; psychoneuroimmunology

DESCRIPTION (provided by applicant): Both the diagnosis of breast cancer as well as the burden of breast cancer treatment put women at risk for emotional distress that may impair cancer-related immune function. The past decade has witnessed an increase in the number of women diagnosed with ductal carcinoma in situ (DCIS) due to the widespread use of screening mammography. DCIS is a growing clinical management challenge as there is limited knowledge of the natural history of DCIS. As a result women with DCIS face difficult treatment choices that must be weighed against not only the risk of cancer recurrence but also their personal values. Remarkably, there is little understanding of the psychological needs of women diagnosed with DCIS. Our preliminary data suggest that women with DCIS have elevated levels of mood disturbance, anxiety, and perceived stress, which are accompanied by immune dysregulation. The implication of such a psychological response upon cancer control mechanisms is considerable. Extensive evidence from the multidisciplinary field of psychoneuroimmunology (PNI) has demonstrated that emotional distress impairs immune function, including NK cell activity and cytokine balance. NK cells and cytokines participate in cancer control and contribute to the protection of an individual from tumor initiation, primary tumor growth, tumor metastasis, and also infectious disease. Therefore, the proposed study will use a PNI framework to investigate the dynamics of the psychological and immunological response of women newly diagnosed with DCIS. In addition, an evaluation will be made of the role of treatment decision-making on the psycho-endocrine-immune response of these women. The specific aims are to: 1) Evaluate the effect of increased mood disturbance, anxiety, and psychological stress on immune function in women who are diagnosed with DCIS (Stage 0) breast cancer at 4 time periods surrounding diagnosis and treatment. 2) Determine whether decisional conflict mediates the effects of mood disturbance, anxiety, and psychological stress on immune function in women who are diagnosed with DCIS. 3) Evaluate a mediation and moderation model of psychological stress and decision making in women diagnosed with DCIS by determining whether: (a) decision making characteristics (decision style, control preference, and satisfaction) moderate the level of decisional conflict experienced by women diagnosed with DCIS and (b) decisional conflict mediates mood disturbance, anxiety, and psychological stress reported by women diagnosed with DCIS. Women newly diagnosed with DCIS (N=122) will be enrolled. A prospective repeated measures design will be used to evaluate mood, state anxiety, psychological stress, serum cortisol, and immune function (NK cells and cytokines) of women with DCIS across the phases of diagnosis, treatment, and post-treatment follow-up. Results will be analyzed with respect to time and in comparison to a group of matched women without cancer. The knowledge obtained will advance the science of PNI by providing insight to the role of a cognitive factor (decision making) on the psycho-endocrine-immune response in women with DCIS. This insight may be used to guide the development of ways to manage decision conflict, which will reduce psychological distress and support immune function in women with breast cancer, as well as other populations facing high stakes treatment decisions.

描述（由申请人提供）：乳腺癌的诊断以及乳腺癌治疗的负担都会使女性面临情绪困扰的风险，从而可能损害癌症相关的免疫功能。过去十年，由于筛查性乳房X光检查的广泛使用，被诊断患有导管原位癌（DCIS）的女性人数有所增加。由于对 DCIS 自然史的了解有限，DCIS 是一个日益严峻的临床管理挑战。因此，患有导管原位癌的女性面临着艰难的治疗选择，不仅必须权衡癌症复发的风险，还要考虑她们的个人价值观。值得注意的是，人们对诊断为 DCIS 的女性的心理需求知之甚少。我们的初步数据表明，患有导管原位癌的女性情绪紊乱、焦虑和感知压力水平升高，并伴有免疫失调。这种心理反应对癌症控制机制的影响是相当大的。来自心理神经免疫学 (PNI) 多学科领域的大量证据表明，情绪困扰会损害免疫功能，包括 NK 细胞活性和细胞因子平衡。 NK 细胞和细胞因子参与癌症控制，并有助于保护个体免受肿瘤发生、原发性肿瘤生长、肿瘤转移以及传染病的影响。因此，拟议的研究将使用 PNI 框架来调查新诊断为 DCIS 的女性心理和免疫反应的动态。此外，还将评估治疗决策对这些女性心理内分泌免疫反应的作用。具体目标是： 1) 评估诊断和治疗周围 4 个时间段内被诊断为 DCIS（0 期）乳腺癌的女性情绪紊乱、焦虑和心理压力增加对免疫功能的影响。 2) 确定决策冲突是否介导情绪障碍、焦虑和心理压力对诊断为 DCIS 的女性免疫功能的影响。 3) 通过确定是否：(a) 决策特征（决策风格、控制偏好和满意度）调节诊断为 DCIS 的女性所经历的决策冲突水平，评估诊断为 DCIS 的女性心理压力和决策的中介和调节模型。 DCIS 和 (b) 决策冲突会介导诊断为 DCIS 的女性的情绪障碍、焦虑和心理压力。新诊断患有导管原位癌 (DCIS) 的女性 (N=122) 将被纳入。前瞻性重复测量设计将用于评估DCIS女性在诊断、治疗和治疗后随访阶段的情绪、状态焦虑、心理压力、血清皮质醇和免疫功能（NK细胞和细胞因子）。结果将根据时间进行分析，并与一组匹配的未患癌症的女性进行比较。所获得的知识将深入了解认知因素（决策）对 DCIS 女性心理内分泌免疫反应的作用，从而推动 PNI 科学的发展。这一见解可用于指导管理决策冲突的方法的开发，这将减少乳腺癌女性以及面临高风险治疗决策的其他人群的心理困扰并支持免疫功能。